3391. Iclusig-H-C-2695-PSUV-0009: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 3392. Stayveer-H-C-PSUSA-00000425-201411 3393. Tafinlar-H-C-2604-PSUV-0005: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 3394. Enurev Breezhaler-H-C-2691-PSUV-0004 3395. Dexdor-H-C-PSUSA-00000998-201703 3396. Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop)-H-C-783-A31-75: EPAR - Scientific conclusions, grounds for variation to the terms of the marketing authorisations and detailed e... 3397. Erivedge-H-C-PSUSA-10140-201601 3398. Nplate-H-C-PSUSA-00002660-201507 3399. Omnitrope-H-C-PSUSA-00002772-201703 3400. Sebivo-H-C-PSUSA-2880-201608 3401. Alimta-H-C-PSUSA-00002330-201502: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 3402. Xeplion-H-C-PSUV-0016 3403. Gilenya-H-C-PSUSA-00001393-201502 3404. Benlysta-H-C-2015-PSUV-19 3405. Ariclaim-H-552-A18-652 3406. Thalidomide Celgene-H-C-PSUSA-00002919-201710: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 3407. Twynsta-H-C-1224-PSU-0007: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 3408. Prometax-H-C-PSUSA/00002654-201501 3409. Cimzia-H-C-1037-PSUV-0041 3410. Incivo-H-C-2313-PSUV-0028 3411. Parsabiv-H-C-PSUSA-00010533-201711: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s) 3412. Tybost-H-C-PSUSA-00010081-201708 3413. Dacogen-H-C-2221-PSUV-0011 3414. Zoledronic acid medac-H-C-PSUSA-3149-201608 3415. Onglyza-H-C-1039-PSU-0022 3416. Ribavirin Mylan-H-C-1185-PSUSA-10007-201307 3417. Prepandrix-H-C-822-PSUV-0049 3418. Ilaris-H-C-1109-PSUV-0032 3419. Pixuvri-H-C-2055-PSUV-0015 3420. Vipidia-H-C-2182-PSUV-0007: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation